Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

M-PEGylation

Pasut, G. and Veronese, F.M. PEGylation of Proteins as Tailored Chemistry for Optimized Bioconjugates. Vol. 192, pp. 95-134. [Pg.239]

Harris, J.M. Martin, N.E. Modi, M. Pegylation a novel process for modifying pharmacokinetics. Clin. Pharmaco-kinet. 2001, 40 (7), 539-551. [Pg.280]

Ghadamosi, 1. K., Hunter, S. C., Moghimi, S. M. PEGylation of microspheres generates a heterogeneous population of particles with differential surface characteristics and biological performance. FEES Lett. 2002, 532, 338-344. [Pg.811]

Figure 3 m-PEGylation using A/-hydroxysuccini-mide ester. [Pg.355]

Yoncheva, K. Lizarraga, E. Irache, J.M. Pegylated nanoparticles based on poly (methyl vinyl ether-comaleic anhydride) Preparation and evaluation of their bioadhesive properties. Eur. J. Pharm. Sci. 2005, 24 (5), 411-419. [Pg.1222]

Felix, A. M. Lu, Y.-A. Campbell, R. M. Pegylated peptides IV. Enhanced biological activity of site-directed pegylated GRF analogs, Int. J. Peptide Protein Res. 1995,46, 253. [Pg.737]

Other IFNs that can be used in the treatment of viral infections include IFN-P, IFN-m, a molecule that is more potent than its nonglycosylated form, which itself has activity comparable to that of IFN-a (Buckwold et al. 2007), and that will be delivered continuously by an implantable device, IFN-y and 1FN-A,1, a pegylated form of which will soon be available. [Pg.213]

Kozlowski A, Charles SA, Harris JM (2001) Development of pegylated interferons for the treatment of chronic hepatitis C. BioDrugs 15 419 29 Krown SE, AeppU D, Balfour HH Jr (1999) Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 20 245-254 LaFleur DW, NardeUi B, Tsareva T, Mather D, Feng P, Semenuk M, Taylor K, Buergin M, Chinchilla D, Roshke V, Chen G, Ruben SM, Pitha PM, Coleman TA, Moore PA (2001) Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J Biol Chem 276 39765-39771... [Pg.236]

Niro GA, Rosina F, Rizzetto M (2005b) Treatment of hepatitis D. J Viral Hepat 12 2-9 Niro GA, Ciancio A, Gaeta GB, SmedUe A, Marrone A, OUvero A, Stanzione M, David E, Bran-caccio G, Fontana R, Perri F, AndriuUi A, Rizzetto M (2006) Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. Hepatology 44 713-720... [Pg.238]

Tamura A, Oishi M, Nagasaki Y (2009) Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. Biomacromolecules 10 1818-1827... [Pg.21]

Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E (1999) PEGylated DNA/transferrin-PEI complexes reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 6 595-605... [Pg.22]

Nie Y, Gunther M, Gu Z, Wagner E (2011) Pyridylhydrazone-based PEGylation for pH-reversible lipopolyplex shielding. Biomaterials 32 858-869... [Pg.28]


See other pages where M-PEGylation is mentioned: [Pg.227]    [Pg.464]    [Pg.399]    [Pg.399]    [Pg.227]    [Pg.251]    [Pg.214]    [Pg.190]    [Pg.209]    [Pg.227]    [Pg.464]    [Pg.399]    [Pg.399]    [Pg.227]    [Pg.251]    [Pg.214]    [Pg.190]    [Pg.209]    [Pg.47]    [Pg.108]    [Pg.231]    [Pg.231]    [Pg.232]    [Pg.235]    [Pg.235]    [Pg.236]    [Pg.237]    [Pg.240]    [Pg.240]    [Pg.242]    [Pg.242]    [Pg.242]    [Pg.341]    [Pg.341]    [Pg.346]    [Pg.721]    [Pg.22]    [Pg.24]    [Pg.135]    [Pg.136]   


SEARCH



PEGylated

PEGylation

© 2024 chempedia.info